Monographs on the medicinal uses of plant drugs. Exeter, UK: European Scientific Co-op Phytother, 1997.

Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Trans. S. Klein. Boston, MA: American Botanical Council, 1998.

Tyler VE. Herbs of Choice. Binghamton, NY: Pharmaceutical Products Press, 1994.

Horton TJ, Geissler CA. Aspirin potentiates the effect of ephedrine on the thermogenic response to a meal in obese but not lean women. Int J Obes 1991;15:359-66. View abstract.

Breum L, Pedersen JK, Ahlstrom F, et al. Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice. Int J Obes Relat Metab Disord 1994;18:99-103. View abstract.

Toubro S, Astrup AV, Breum L, Quaade F. fety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture. Int J Obes Relat Metab Disord 1993;17:S69-72. View abstract.

Dulloo AG, Miller DS. Aspirin as a promoter of ephedrine-induced thermogenesis: potential use in the treatment of obesity. Am J Clin Nutr 1987;45:564-9. View abstract.

Okada S, Rohan PJ, Miller FW, et al. Myopathies following ingestion of special nutritional products. Arthritis Rheum 1996;39:349.

Zaacks SM, Klein L, Tan CD, et al. Hypersensitivity myocarditis associated with ephedra use. J Toxicol Clin Toxicol 1999;37:485-9. View abstract.

Powell T, Hsu FF, Turk J, Hruska K. Ma-huang strikes again: ephedrine nephrolithiasis. Am J Kidney Dis 1998;32:153-9. View abstract.

Nadir A, Agrawal S, King PD, Marshall JB. Acute hepatitis associated with the use of a Chinese herbal product, ma-huang. Am J Gastroenterol 1996;91:1436-8. View abstract.

Theoharides TC. Sudden death of a healthy college student related to ephedrine toxicity from a ma-huang containing drink. J Clin Psychopharmacol 1997;17:437-9.

Vahedi K, Domingo V, Amarenco P, Bousser MG. Ischemic stroke in a sportsman who consumed MaHuang extract and creatine monohydrate for bodybuilding. J Neurol Neurosurg Psychiatr 2000;68:112-3. View abstract.

Doyle H, Kargin M. Herbal stimulant containing ephedrine has also caused psychosis. BMJ 1996;313:756. View abstract.

FDA Takes Aim at Ephedra. The Washington Post. Available at: http://www.washingtonpost.com/archive/politics/2000/03/19/fda-takes-aim-at-ephedra/4ce534a7-d291-44ec-88a8-38e97ff27e3b/ (Accessed 19 March 2000).

Louis E. Tremor disorders: identification and treatment. Medical Update for Psychiatrists 1997;2:172-6.

FDA. Proposed rule: dietary supplements containing ephedrine alkaloids. Available at: www.verity.fda.gov (Accessed 25 January 2000).

Boozer CN, Nasser JA, Heymsfield SB, et al. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial. Int J Obes Relat Metab Disord 2001;25:316-24. View abstract.

FDA announces the availability of new Ephedrine and street drug alternative docs. Available at: www.fda.gov (Accessed 6 April 2000).

Gurley BJ, Gardner SF, Hubbard MA. Content versus label claims in ephedra-containing dietary supplements. Am J Health Syst Pharm 2000;57:963-9. View abstract.

White LM, Gardner SF, Gurley BJ, et al. Pharmacokinetics and Cardiovascular Effects of Ma-Huang (Ephedra sinica) in Normotensive Adults. J Clin Pharmacol 1997;37:116-22. View abstract.

Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000;343:1833-8. View abstract.

Leikin JB, Klein L. Ephedra causes myocarditis. Clin Toxicol 2000;38:353-4.

Gurley B. Extract versus herb: Effect of formulation on the absorption rate of botanical ephedrine from dietary supplements containing ephedra (ma huang). Ther Drug Monit 2000;22:497.

Jacobs KM, Hirsch KA. Psychiatric complications of Ma-huang. Psychosomatics 2000;41:58-62. View abstract.

Atkinson RL. The herbal ephedra and caffeine debate continues. Int J Obes Relat Metab Disord 2002;26:589.

Dulloo AG. Herbal simulation of ephedrine and caffeine in treatment of obesity. Int J Obes Relat Metab Disord 2002;26:590-2.

Lindsay BD. Are serious adverse cardiovascular events an unintended consequence of the Dietary Supplement Health and Education Act of 1994? Mayo Clin Proc 2002;77:7-9. View abstract.

Samenuk D, Link MS, Homoud MK, et al. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc 2002;77:12-6. View abstract.

Haller CA, Jacob P 3rd, Benowitz NL. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use. Clin Pharmacol Ther 2002;71:421-32. View abstract.

Greenway FL, Raum WJ, DeLany JP. The effect of an herbal dietary supplement containing ephedrine and caffeine on oxygen consumption in humans. J Altern Complement Med 2000;6:553-5. View abstract.

Bell DG, Jacobs I, Ellerington K. Effect of caffeine and ephedrine ingestion on anaerobic exercise performance. Med Sci Sports Exerc 2001;33:1399-403. View abstract.

Boozer CN, Daly PA, Homel P, et al. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. Int J Obes Relat Metab Disord 2002;26:593-604. View abstract.

Morgenstern LB, Viscoli CM, Kernan WN, et al. Use of Ephedra-containing products and risk for hemorrhagic stroke. Neurology 2003;60:132-5. . View abstract.

Bent S, Tiedt TN, Odden MC, Shilpak MG. The relative safety of ephedra compared with other herbal products. Ann Intern Med 2003;138:468-71. View abstract.

Shekelle PG, Hardy ML, Morton SC, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA 2003;289:1537-45.. View abstract.

Anon. Ephedra and ephedrine for weight loss and athletic performance enhancement: clinical efficacy and side effects. Evid Rep Technol Assess (Summ) 2003;76:1-4.

Dulloo AG, Miller DS. Ephedrine, caffeine and aspirin: "over-the-counter" drugs that interact to stimulate thermogenesis in the obese. Nutrition 1989;5:7-9.

Kalman D, Incledon T, Gaunaurd I, et al. An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra-caffeine weight loss product in healthy overweight adults. Int J Obes 2002;26:1363-66.. View abstract.

Schweinfurth J, Pribitkin E. Sudden hearing loss associated with ephedra use. Am J Health Syst Pharm 2003;60:375-7.

Food and Drug Administration, HHS. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk; Final rule. Fed Regist 2004;69:6787-6854. View abstract.

Kockler DR, McCarthy MW, Lawson CL. Seizure activity and unresponsiveness after hydroxycut ingestion. Pharmacotherapy 2001;21:647-51.. View abstract.

Yates KM, O'Connor A, Horsley CA. "Herbal Ecstasy": a case series of adverse reactions. N Z Med J 2000;113:315-7.. View abstract.

Levisky JA, Karch SB, Bowerman DL, et al. False-positive RIA for methamphetamine following ingestion of an Ephedra-derived herbal product. J Anal Toxicol 2003;27:123-4.

Walton R, Manos GH. Psychosis related to ephedra-containing herbal supplement use. South Med J 2003;96:718-20.. View abstract.

Jenkins DJ, Wesson V, Wolever TM, et al. Wholemeal versus wholegrain breads: proportion of whole or cracked grain and the glycaemic response. BMJ 1988;297:958-60. View abstract.

Baker J, Zhang X, Boucher T, Keyler D. Investigation of quality in ephedrine-containing dietary supplements. Journal of Herbal Pharmacotherapy 2003;3:5-17.

McBride BF, Karapanos AK, Krudysz A, et al. Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial. JAMA 2004;291:216-21. View abstract.

Brooks SM, Sholiton LJ, Werk EE Jr, Altenau P. The effects of ephedrine and theophylline on dexamethasone metabolism in bronchial asthma. J Clin Pharmacol 1977;17:308-18. View abstract.

Gardner SF, Franks AM, Gurley BJ, et al. Effect of a multicomponent, ephedra-containing dietary supplement (Metabolife 356) on Holter monitoring and hemostatic parameters in healthy volunteers. Am J Cardiol 2003;91:1510-3, A9.

Coffey CS, Steiner D, Baker BA, Allison DB. A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment. Int J Obes Relat Metab Disord 2004;28:1411-9. View abstract.

Soni MG, Carabin IG, Griffiths JC, Burdock GA. Safety of ephedra: lessons learned. Toxicol Lett 2004;150:97-110. View abstract.

Vukovich MD, Schoorman R, Heilman C, et al. Caffeine-herbal ephedra combination increases resting energy expenditure, heart rate and blood pressure. Clin Exp Pharmacol Physiol 2005;32:47-53. View abstract.

Haller CA, Jacob P 3rd, Benowitz NL. Enhanced stimulant and metabolic effects of combined ephedrine and caffeine. Clin Pharmacol Ther 2004;75:259-73. View abstract.

Wilson BE, Hobbs WN. Case report: pseudoephedrine-associated thyroid storm: thyroid hormone-catecholamine interactions. Am J Med Sci 1993;306:317-9. View abstract.

Ujino H, Morimoto O, Yukioka H, Fujimori M. [Acute angle-closure glaucoma after total hip replacement surgery]. Masui 1997;46:823-6. View abstract.

Wilde-Mathews A, Schaefer-Munoz S. Judge overturns ban on ephedra, roils FDA policy. Wall Street Journal, April 15, 2005. Available at: http://www.wsj.com/articles/SB111350487573807266.

Anon. High-dose ephedra pills still illegal, FDA says. Reuters, April 15, 2005.

Haller CA, Meier KH, Olson KR. Seizures reported in association with use of dietary supplements. Clin Toxicol (Phila) 2005;43:23-30. View abstract.

Vierck JL, Icenoggle DL, Bucci L, Dodson MV. The effects of ergogenic compounds on myogenic satellite cells. Med Sci Sports Exerc 2003;35:769-76. View abstract.

FDA Statement on Tenth Circuit's Ruling to Uphold FDA Decision Banning Dietary Supplements Containing Ephedrine Alkaloids. FDA Statement, August 21, 2006. Available at: http://www.fda.gov/bbs/topics/NEWS/2006/NEW01434.html.

Burke J, Seda G, Allen D, Knee TS. A case of severe exercise-induced rhabdomyolysis associated with a weight loss dietary supplement. Mil Med 2007;172:656-8. View abstract.

Dawson, J. K., Earnshaw, S. M., and Graham, C. S. Dangerous monoamine oxidase inhibitor interactions are still occurring in the 1990s. J Accid.Emerg.Med 1995;12(1):49-51. View abstract.

Weinberger M and Bronsky E. Interaction of ephedrine and theophylline. Clin Pharmacol Ther 1974;15(2):223.

Kernan, W. N., Viscoli, C. M., Brass, L. M., Broderick, J. P., Brott, T., Feldmann, E., Morgenstern, L. B., Wilterdink, J. L., and Horwitz, R. I. Phenylpropanolamine and the risk of hemorrhagic stroke. N.Engl.J Med 12-21-2000;343(25):1826-1832. View abstract.

Jubiz, W. and Meikle, A. W. Alterations of glucocorticoid actions by other drugs and disease states. Drugs 1979;18(2):113-121. View abstract.

Thomas, J. E., Munir, J. A., McIntyre, P. Z., and Ferguson, M. A. STEMI in a 24-year-old man after use of a synephrine-containing dietary supplement: a case report and review of the literature. Tex.Heart Inst.J 2009;36(6):586-590. View abstract.

Cohen, P. A. and Ernst, E. Safety of herbal supplements: a guide for cardiologists. Cardiovasc.Ther 2010;28(4):246-253. View abstract.

Astrup, A., Breum, L., Toubro, S., Hein, P., and Quaade, F. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial. Int.J.Obes.Relat Metab Disord. 1992;16(4):269-277. View abstract.

Greenway, F. L., De Jonge, L., Blanchard, D., Frisard, M., and Smith, S. R. Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition. Obes.Res. 2004;12(7):1152-1157. View abstract.

Hackman, R. M., Havel, P. J., Schwartz, H. J., Rutledge, J. C., Watnik, M. R., Noceti, E. M., Stohs, S. J., Stern, J. S., and Keen, C. L. Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial. Int J Obes.(Lond) 2006;30(10):1545-1556. View abstract.

Williams, A. D., Cribb, P. J., Cooke, M. B., and Hayes, A. The effect of ephedra and caffeine on maximal strength and power in resistance-trained athletes. J Strength.Cond.Res 2008;22(2):464-470. View abstract.

Hasani-Ranjbar, S., Nayebi, N., Larijani, B., and Abdollahi, M. A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World J Gastroenterol. 7-7-2009;15(25):3073-3085. View abstract.

Friedrich, H. and Wiedemeyer, H. [Quantitative determination of the tannin-precursors and the tannins in Ephedra helvetica (author's transl)]. Planta Med 1976;30(3):223-231. View abstract.

Gurley, B. J., Wang, P., and Gardner, S. F. Ephedrine-type alkaloid content of nutritional supplements containing Ephedra sinica (Ma-huang) as determined by high performance liquid chromatography. J Pharm Sci 1998;87(12):1547-1553. View abstract.

Lovstad, R. Z., Granhus, G., and Hetland, S. Bradycardia and asystolic cardiac arrest during spinal anaesthesia: a report of five cases. Acta Anaesthesiol.Scand 2000;44(1):48-52. View abstract.

Ngan Kee, W. D., Khaw, K. S., Lee, B. B., Lau, T. K., and Gin, T. A dose-response study of prophylactic intravenous ephedrine for the prevention of hypotension during spinal anesthesia for cesarean delivery. Anesth.Analg. 2000;90(6):1390-1395. View abstract.

Kurt, T. L. Hypersensitivity myocarditis with ephedra use. J Toxicol.Clin Toxicol. 2000;38(3):351. View abstract.

Leikin, J. B. and Klein, L. Ephedra causes myocarditis. J Toxicol.Clin Toxicol. 2000;38(3):353-354. View abstract.

Weinberger, M. M. Use of ephedrine in bronchodilator therapy. Pediatr Clin North Am 1975;22(1):121-127. View abstract.

Tashkin, D. P., Meth, R., Simmons, D. H., and Lee, Y. E. Double-blind comparison of acute bronchial and cardiovascular effects of oral terbutaline and ephedrine. Chest 1975;68(2):155-161. View abstract.

Molnar, D., Torok, K., Erhardt, E., and Jeges, S. Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents. Int J Obes.Relat Metab Disord. 2000;24(12):1573-1578. View abstract.

Borum, M. L. Fulminant exacerbation of autoimmune hepatitis after the use of ma huang. Am J Gastroenterol. 2001;96(5):1654-1655. View abstract.

Ngan Kee, W. D., Lau, T. K., Khaw, K. S., and Lee, B. B. Comparison of metaraminol and ephedrine infusions for maintaining arterial pressure during spinal anesthesia for elective cesarean section. Anesthesiology 2001;95(2):307-313. View abstract.

Blanck, H. M., Khan, L. K., and Serdula, M. K. Use of nonprescription weight loss products: results from a multistate survey. JAMA 8-22-2001;286(8):930-935. View abstract.

Ayorinde, B. T., Buczkowski, P., Brown, J., Shah, J., and Buggy, D. J. Evaluation of pre-emptive intramuscular phenylephrine and ephedrine for reduction of spinal anaesthesia-induced hypotension during Caesarean section. Br.J.Anaesth. 2001;86(3):372-376. View abstract.

Tormey, W. P. and Bruzzi, A. Acute psychosis due to the interaction of legal compounds--ephedra alkaloids in 'vigueur fit' tablets, caffeine in 'red bull' and alcohol. Med Sci Law 2001;41(4):331-336. View abstract.

Traboulsi, A. S., Viswanathan, R., and Coplan, J. Suicide attempt after use of herbal diet pill. Am J Psychiatry 2002;159(2):318-319. View abstract.

Ducros, L., Bonnin, P., Cholley, B. P., Vicaut, E., Benayed, M., Jacob, D., and Payen, D. Increasing maternal blood pressure with ephedrine increases uterine artery blood flow velocity during uterine contraction. Anesthesiology 2002;96(3):612-616. View abstract.

Loughrey, J. P., Walsh, F., and Gardiner, J. Prophylactic intravenous bolus ephedrine for elective Caesarean section under spinal anaesthesia. Eur J Anaesthesiol. 2002;19(1):63-68. View abstract.

Lee, A., Ngan Kee, W. D., and Gin, T. A quantitative, systematic review of randomized controlled trials of ephedrine versus phenylephrine for the management of hypotension during spinal anesthesia for cesarean delivery. Anesth.Analg. 2002;94(4):920-6. View abstract.

Dulloo, A. G. Herbal simulation of ephedrine and caffeine in treatment of obesity. Int.J.Obes.Relat Metab Disord. 2002;26(5):590-592. View abstract.

Gotz, M. [Long-term out-patient treatment of children with asthma with a theophylline-ephedrine-hydroxyzine combination (author's transl)]. Padiatr.Padol. 1975;10(4):466-473. View abstract.

May, C. S., Pickup, M. E., and Paterson, J. W. The acute and chronic bronchodilator effects of ephedrine in asthmatic patients. Br J Clin Pharmacol 1975;2(6):533-537. View abstract.

Schweinfurth, J. and Pribitkin, E. Sudden hearing loss associated with ephedra use. Am J Health Syst Pharm 2-15-2003;60(4):375-377. View abstract.

Levisky, J. A., Karch, S. B., Bowerman, D. L., Jenkins, W. W., Johnson, D. G., and Davies, D. False-positive RIA for methamphetamine following ingestion of an Ephedra-derived herbal product. J Anal.Toxicol. 2003;27(2):123-124. View abstract.

Gardner, S. F., Franks, A. M., Gurley, B. J., Haller, C. A., Singh, B. K., and Mehta, J. L. Effect of a multicomponent, ephedra-containing dietary supplement (Metabolife 356) on Holter monitoring and hemostatic parameters in healthy volunteers. Am J Cardiol. 6-15-2003;91(12):1510-3, A9. View abstract.

Kalman, D. S., Antonio, J., and Kreider, R. B. The relative safety of ephedra compared with other herbal products. Ann Intern Med 6-17-2003;138(12):1006-1007. View abstract.

Kimmel, S. E. The relative safety of ephedra compared with other herbal products. Ann Intern Med 8-5-2003;139(3):234. View abstract.

Karch, S. B. Use of Ephedra-containing products and risk for hemorrhagic stroke. Neurology 9-9-2003;61(5):724-725. View abstract.

Whitaker, J. M. The relative safety of ephedra compared with other herbal products. Ann Intern Med 9-2-2003;139(5 Pt 1):385-387. View abstract.

Dickinson, A. The relative safety of ephedra compared with other herbal products. Ann Intern Med 9-2-2003;139(5 Pt 1):385-387. View abstract.

Kingston, R. L. and Borron, S. W. The relative safety of ephedra compared with other herbal products. Ann Intern Med 9-2-2003;139(5 Pt 1):385-387. View abstract.

Pasquali, R., Casimirri, F., Melchionda, N., Grossi, G., Bortoluzzi, L., Morselli Labate, A. M., Stefanini, C., and Raitano, A. Effects of chronic administration of ephedrine during very-low-calorie diets on energy expenditure, protein metabolism and hormone levels in obese subjects. Clin Sci (Colch.) 1992;82(1):85-92. View abstract.

Dulloo, A. G., Seydoux, J., and Girardier, L. Potentiation of the thermogenic antiobesity effects of ephedrine by dietary methylxanthines: adenosine antagonism or phosphodiesterase inhibition? Metabolism 1992;41(11):1233-1241. View abstract.

Hioki, C., Yoshimoto, K., and Yoshida, T. Efficacy of bofu-tsusho-san, an oriental herbal medicine, in obese Japanese women with impaired glucose tolerance. Clin.Exp.Pharmacol.Physiol 2004;31(9):614-619. View abstract.

Alahuhta, S., Rasanen, J., Jouppila, P., Jouppila, R., and Hollmen, A. I. Ephedrine and phenylephrine for avoiding maternal hypotension due to spinal anaesthesia for caesarean section. Effects on uteroplacental and fetal haemodynamics. Int.J.Obstet.Anesth. 1992;1(3):129-134. View abstract.

Chen-Scarabelli, C., Hughes, S. E., Landon, G., Rowley, P., Allebban, Z., Lawson, N., Saravolatz, L., Gardin, J., Latchman, D., and Scarabelli, T. M. A case of fatal ephedra intake associated with lipofuscin accumulation, caspase activation and cleavage of myofibrillary proteins. Eur J Heart Fail. 2005;7(5):927-930. View abstract.

Barker, W. D. and Antia, U. A study of the use of Ephedra in the manufacture of methamphetamine. Forensic Sci Int 3-2-2007;166(2-3):102-109. View abstract.

Moawad, F. J., Hartzell, J. D., Biega, T. J., and Lettieri, C. J. Transient blindness due to posterior reversible encephalopathy syndrome following ephedra overdose. South Med J 2006;99(5):511-514. View abstract.

Minamizawa, K., Goto, H., Shimada, Y., Terasawa, K., and Haji, A. Effects of eppikahangeto, a Kampo formula, and Ephedrae herba against citric acid-induced laryngeal cough in guinea pigs. J Pharmacol Sci 2006;101(2):118-125. View abstract.

Stahl, C. E., Borlongan, C. V., Szerlip, M., and Szerlip, H. No pain, no gain--exercise-induced rhabdomyolysis associated with the performance enhancer herbal supplement ephedra. Med Sci Monit. 2006;12(9):CS81-CS84. View abstract.

Caron, M. F., Dore, D. D., Min, B., Kluger, J., Boguk, I., and White, C. M. Electrocardiographic and blood pressure effects of the ephedra-containing TrimSpa thermogenic herbal compound in healthy volunteers. Pharmacotherapy 2006;26(9):1241-1246. View abstract.

Jonderko, K. and Kucio, C. Effect of anti-obesity drugs promoting energy expenditure, yohimbine and ephedrine, on gastric emptying in obese patients. Aliment.Pharmacol Ther 1991;5(4):413-418. View abstract.

Cui, J. F., Niu, C. Q., and Zhang, J. S. [Determination of six Ephedra alkaloids in Chinese Ephedra (Ma Huang) by gas chromatography]. Yao Xue.Xue.Bao. 1991;26(11):852-857. View abstract.

Vigano, M., Lampertico, P., and Colombo, M. Acute hepatitis following assumption of a herbal remedy. Eur.J.Gastroenterol.Hepatol. 2008;20(4):364-365. View abstract.

Singh, A., Rajeev, A. G., and Dohrmann, M. L. Cardiomyopathy associated with ephedra-containing nutritional supplements. Congest.Heart Fail. 2008;14(2):89-90. View abstract.

Zhang, Y., Chang, J., Zhang, R. M., Liu, L. L., Li, F. S., Jiang, X. Y., Wang, L., Mao, B., and Li, T. Q. [Mahuang Zhisou Capsule in treatment of acute upper respiratory tract infection of external wind-cold syndrome: a multi-center, randomized controlled, and double-blind trial]. Zhong.Xi.Yi.Jie.He.Xue.Bao. 2008;6(6):581-585. View abstract.

Song, H. J., Shim, K. N., Ryu, K. H., Kim, T. H., Jung, S. A., and Yoo, K. A case of ischemic colitis associated with the herbal food supplement ma huang. Yonsei Med.J. 6-30-2008;49(3):496-499. View abstract.

Flanagan, C. M., Kaesberg, J. L., Mitchell, E. S., Ferguson, M. A., and Haigney, M. C. Coronary artery aneurysm and thrombosis following chronic ephedra use. Int.J.Cardiol. 2-18-2010;139(1):e11-e13. View abstract.

Hallas, J., Bjerrum, L., Stovring, H., and Andersen, M. Use of a prescribed ephedrine/caffeine combination and the risk of serious cardiovascular events: a registry-based case-crossover study. Am J Epidemiol. 10-15-2008;168(8):966-973. View abstract.

Moran, D. H., Perillo, M., LaPorta, R. F., Bader, A. M., and Datta, S. Phenylephrine in the prevention of hypotension following spinal anesthesia for cesarean delivery. J.Clin.Anesth. 1991;3(4):301-305. View abstract.

Astrup, A., Toubro, S., Cannon, S., Hein, P., and Madsen, J. Thermogenic synergism between ephedrine and caffeine in healthy volunteers: a double-blind, placebo-controlled study. Metabolism 1991;40(3):323-329. View abstract.

Pinnas, J. L., Schachtel, B. P., Chen, T. M., Roseberry, H. R., and Thoden, W. R. Inhaled epinephrine and oral theophylline-ephedrine in the treatment of asthma. J Clin Pharmacol 1991;31(3):243-247. View abstract.

Martinez-Quintana, E., Rodriguez-Gonzalez, F., and Cuba-Herrera, J. [Myocardial necrosis and severe biventricular dysfunction in the context of chronic ephedrine abuse]. Adicciones. 2010;22(1):25-28. View abstract.

Chen, Z. X. and Hu, G. H. [Effect of modified shegan mahuang decoction on cytokines in children patients with cough and variant asthma]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 2010;30(2):208-210. View abstract.

Chen, W. L., Tsai, T. H., Yang, C. C., and Kuo, T. B. Acute effects of ephedra on autonomic nervous modulation in healthy young adults. Clin.Pharmacol.Ther. 2010;88(1):39-44. View abstract.

Chen, W. L., Tsai, T. H., Yang, C. C., and Kuo, T. B. Effects of ephedra on autonomic nervous modulation in healthy young adults. J.Ethnopharmacol. 8-9-2010;130(3):563-568. View abstract.

Kim, H. J., Park, J. M., Kim, J. A., and Ko, B. P. Effect of herbal Ephedra sinica and Evodia rutaecarpa on body composition and resting metabolic rate: a randomized, double-blind clinical trial in Korean premenopausal women. J.Acupunct.Meridian.Stud. 2008;1(2):128-138. View abstract.

Jiang, M. H., Liu, L., Wang, Q. A., Zhan, W. X., and Shu, H. D. [Effects of ephedrine and its analogs on beta-adrenoceptors of rat lung cell membranes]. Zhongguo Yao Li Xue.Bao. 1987;8(4):318-320. View abstract.

Tinkelman, D. G. and Avner, S. E. Ephedrine therapy in asthmatic children. Clinical tolerance and absence of side effects. JAMA 2-7-1977;237(6):553-557. View abstract.

Pasquali, R., Cesari, M. P., Melchionda, N., Stefanini, C., Raitano, A., and Labo, G. Does ephedrine promote weight loss in low-energy-adapted obese women? Int J Obes. 1987;11(2):163-168. View abstract.

Dulloo, A. G. and Miller, D. S. Reversal of obesity in the genetically obese fa/fa Zucker rat with an ephedrine/methylxanthines thermogenic mixture. J Nutr 1987;117(2):383-389. View abstract.

Zarrindast, M. R., Hosseini-Nia, T., and Farnoodi, F. Anorectic effect of ephedrine. Gen.Pharmacol 1987;18(5):559-561. View abstract.

Direkwattanachai, C., Phanichyakarn, P., and Srianujatra, S. Sustained release theophylline and ephedrine therapy in chronic asthma. J Med Assoc Thai 1986;69 Suppl 2:31-37. View abstract.

Pasquali, R., Baraldi, G., Cesari, M. P., Melchionda, N., Zamboni, M., Stefanini, C., and Raitano, A. A controlled trial using ephedrine in the treatment of obesity. Int J Obes. 1985;9(2):93-98. View abstract.

Dulloo, A. G. and Miller, D. S. The thermogenic properties of ephedrine/methylxanthine mixtures: animal studies. Am J Clin Nutr 1986;43(3):388-394. View abstract.

Astrup, A., Lundsgaard, C., Madsen, J., and Christensen, N. J. Enhanced thermogenic responsiveness during chronic ephedrine treatment in man. Am J Clin Nutr 1985;42(1):83-94. View abstract.

Hughes, S. C., Ward, M. G., Levinson, G., Shnider, S. M., Wright, R. G., Gruenke, L. D., and Craig, J. C. Placental transfer of ephedrine does not affect neonatal outcome. Anesthesiology 1985;63(2):217-219. View abstract.

Konno, C., Mizuno, T., and Hikino, H. Isolation and hypoglycemic activity of ephedrans A, B, C, D and E, glycans of Ephedra distachya herbs. Planta Med 1985;(2):162-163. View abstract.

Furukawa, T. and Kuroda, M. [Effects of ephedrine, tyramine and norepinephrine on the blood pressure response to dopamine]. Nippon Yakurigaku Zasshi 1974;70(3):377-384. View abstract.

Weinberger, M. M. and Bronsky, E. A. Evaluation of oral bronchodilator therapy in asthmatic children. Bronchodilators in asthmatic children. J Pediatr 1974;84(3):421-427. View abstract.

Taylor, W. F., Heimlich, E. M., Strick, L., and Busser, R. Ephedrine and theophylline in asthmatic children: quantitive observations on the combination and ephedrine tachyphylaxis. Ann Allergy 1965;23(9):437-440. View abstract.

Saito, H. [Mechanisms of reversal of the blood pressure by ephedrine. (1)]. Nippon Yakurigaku Zasshi 1977;73(1):73-82. View abstract.

Saito, H. [Mechanism of reversal of the blood pressure by ephedrine. (2)]. Nippon Yakurigaku Zasshi 1977;73(1):83-92. View abstract.

Herridge, C. F. and a'Brook, M. F. Ephedrine psychosis. Br Med J 4-20-1968;2(598):160. View abstract.

Unger, D. L. Blood pressure and pulse rate changes in hypertensive asthmatic patients: effects of an ephedrine compound. Ann Allergy 1968;26(12):637-638. View abstract.

Roxanas, M. G. and Spalding, J. Ephedrine abuse psychosis. Med J Aust. 11-5-1977;2(19):639-640. View abstract.

Dulloo, A. G. and Miller, D. S. Thermogenic drugs for the treatment of obesity: sympathetic stimulants in animal models. Br J Nutr 1984;52(2):179-196. View abstract.

Arch, J. R., Ainsworth, A. T., and Cawthorne, M. A. Thermogenic and anorectic effects of ephedrine and congeners in mice and rats. Life Sci 5-24-1982;30(21):1817-1826. View abstract.

McLaughlin, E. T., Bethea, L. H., and Wittig, H. J. Comparison of the bronchodilator effect of oral fenoterol and ephedrine in asthmatic children. Ann Allergy 1982;49(4):191-195. View abstract.

Wright, R. G., Shnider, S. M., Levinson, G., Rolbin, S. H., and Parer, J. T. The effect of maternal administration of ephedrine on fetal heart rate and variability. Obstet Gynecol 1981;57(6):734-738. View abstract.

Yen, T. T., McKee, M. M., and Bemis, K. G. Ephedrine reduces weight of viable yellow obese mice (Avy/a). Life Sci 1-12-1981;28(2):119-128. View abstract.

Hikino, H., Konno, C., Takata, H., and Tamada, M. Antiinflammatory principle of Ephedra Herbs. Chem Pharm Bull (Tokyo) 1980;28(10):2900-2904. View abstract.

Shaikh, W. A. Ephedrine-saline nasal wash in allergic rhinitis. J Allergy Clin Immunol. 1995;96(5 Pt 1):597-600. View abstract.

Ueda, W., Kataoka, Y., Takimoto, E., Tomoda, M. K., Aono, J., Sagara, Y., and Manabe, M. Ephedrine-induced increases in arterial blood pressure accelerate regression of epidural block. Anesth.Analg. 1995;81(4):703-705. View abstract.

Capwell, R. R. Ephedrine-induced mania from an herbal diet supplement. Am J Psychiatry 1995;152(4):647. View abstract.

Wang, G. Z. and Hikokichi, O. [Experimental study in treating chronic renal failure with dry extract and tannins of herba ephedra]. Chinsese Journal of Integrated Traditional and Western Medicine 1994;14(8):485-488. View abstract.

Shufman, N. E., Witztum, E., and Vass, A. [Ephedrine psychosis]. Harefuah 1994;127(5-6):166-8, 215. View abstract.

Hall, P. A., Bennett, A., Wilkes, M. P., and Lewis, M. Spinal anaesthesia for caesarean section: comparison of infusions of phenylephrine and ephedrine. Br.J.Anaesth. 1994;73(4):471-474. View abstract.

Lyons, H. A., Thomas, J. S., and Steen, S. N. Theophylline and ephedrine in asthma. Curr Ther Res Clin Exp 1975;18(4):573-577. View abstract.

Pierce, E. T., Carr, D. B., and Datta, S. Effects of ephedrine and phenylephrine on maternal and fetal atrial natriuretic peptide levels during elective cesarean section. Acta Anaesthesiol.Scand. 1994;38(1):48-51. View abstract.

Faurschou, M. and Svendsen, U. G. [The bronchodilating effect of ephedrine tablets in bronchial asthma]. Ugeskr.Laeger 11-15-1993;155(46):3784-3785. View abstract.

Bruno, A., Nolte, K. B., and Chapin, J. Stroke associated with ephedrine use. Neurology 1993;43(7):1313-1316. View abstract.

Dulloo, A. G. Ephedrine, xanthines and prostaglandin-inhibitors: actions and interactions in the stimulation of thermogenesis. Int J Obes.Relat Metab Disord. 1993;17 Suppl 1:S35-S40. View abstract.

Astrup, A. and Toubro, S. Thermogenic, metabolic, and cardiovascular responses to ephedrine and caffeine in man. Int J Obes.Relat Metab Disord. 1993;17 Suppl 1:S41-S43. View abstract.

Daly, P. A., Krieger, D. R., Dulloo, A. G., Young, J. B., and Landsberg, L. Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human obesity. Int J Obes.Relat Metab Disord. 1993;17 Suppl 1:S73-S78. View abstract.

Hirabayashi, Y., Saitoh, K., Fukuda, H., Mitsuhata, H., and Shimizu, R. Coronary artery spasm after ephedrine in a patient with high spinal anesthesia. Anesthesiology 1996;84(1):221-224. View abstract.

Thomas, D. G., Robson, S. C., Redfern, N., Hughes, D., and Boys, R. J. Randomized trial of bolus phenylephrine or ephedrine for maintenance of arterial pressure during spinal anaesthesia for Caesarean section. Br.J.Anaesth. 1996;76(1):61-65. View abstract.

LaPorta, R. F., Arthur, G. R., and Datta, S. Phenylephrine in treating maternal hypotension due to spinal anaesthesia for caesarean delivery: effects on neonatal catecholamine concentrations, acid base status and Apgar scores. Acta Anaesthesiol.Scand. 1995;39(7):901-905. View abstract.

Perrotta DM. From the Centers for Disease Control and Prevention. Adverse events associated with ephedrine-containing products--Texas, December 1993- September 1995. JAMA 12-4-1996;276(21):1711-1712. View abstract.

Cockings, J. G. and Brown, M. Ephedrine abuse causing acute myocardial infarction. Med J Aust 8-18-1997;167(4):199-200. View abstract.

Ramsey, J. J., Colman, R. J., Swick, A. G., and Kemnitz, J. W. Energy expenditure, body composition, and glucose metabolism in lean and obese rhesus monkeys treated with ephedrine and caffeine. Am J Clin Nutr 1998;68(1):42-51. View abstract.

Meston, C. M. and Heiman, J. R. Ephedrine-activated physiological sexual arousal in women. Arch Gen.Psychiatry 1998;55(7):652-656. View abstract.

Blau, J. J. Ephedrine nephrolithiasis associated with chronic ephedrine abuse. J Urol. 1998;160(3 Pt 1):825. View abstract.

Shekelle P, Morton, S, Maglione, M, and et al. Ephedra and Ephedrine for Weight Loss and Athletic Performance Enhancement: Clinical Efficacy and Side Effects. Evidence Report/Technology Assessment No. 76 (Prepared by Southern California Evidence-based Practice Center, RAND, under Contract No 290-97-0001, Task Order No. 9). Agency for Healthcare Research and Quality. Rockville, MD. February, 2003.

Liu YM and Sheu SJ. Determination of Ephedrine alkaloids by capillary electrophoresis. J Chromatog 1992;600:370-372.

Martinet A, Hostettmann K, and Schutz Y. Thermogenic effects of commercially available phytotherapy compounds aimed at treating human obesity. Phytomedicine 1999;6(4):S174.

Atkinson RL. The herbal ephedra and caffeine debate continues. Int J Obes Relat Metab Disord 2002;26:589.

Munns G and Aldrich C. Ephedrine in the treatment of bronchial asthma in children. JAMA 1927;88:1233.

Gardner R, Hansen A, and Eewing P. Unexpected fatality in a child from accidental consumption of antiasthmatic preparation containing ephedrine, theophylline and phenobarbital. Texas State J Med 1950;46:516-520.

Ryall JE. Caffeine and ephedrine fatality. Bull Int Assoc Forensic Toxicol 1984;17:13.

Rejent T, Michalek R, and Krajewski M. Caffeine fatality with coincident ephedrine. Bull Int Assoc Forensic Toxicol 1981;16:18-19.

Neff, G. W., Reddy, K. R., Durazo, F. A., Meyer, D., Marrero, R., and Kaplowitz, N. Severe hepatotoxicity associated with the use of weight loss diet supplements containing ma huang or usnic acid. J Hepatol. 2004;41(6):1062-1064. View abstract.

Kim BS, Song MY, Kim H. The anti-obesity effect of Ephedra sinica through modulation of gut microbiota in obese Korean women. J Ethnopharmacol. 2014;152(3):532-9. View abstract.

Tang J, Zhou X, Ji H, Zhu D, Wu L. Effects of ephedra water decoction and cough tablets containing ephedra and liquorice on CYP1A2 and the pharmacokinetics of theophylline in rats. Phytother Res. 2012;26(3):470-4. View abstract.

Bajaj J, Knox JF, Komorowski R, Saeian K. The irony of herbal hepatitis: Ma-Huang-induced hepatotoxicity associated with compound heterozygosity for hereditary hemochromatosis. Dig Dis Sci. 2003;48(10):1925-8. View abstract.

Charalampopoulos A, Karatsourakis T, Tsiodra P. Acute hepatitis associated with the use of Ma-huang in a young adult. Eur J Intern Med. 2007;18(1):81. View abstract.

Skoulidis F, Alexander GJ, Davies SE. Ma huang associated acute liver failure requiring liver transplantation. Eur J Gastroenterol Hepatol. 2005;17(5):581-4. View abstract.

Drug record: Ma huang. U.S. National Library of Medicine: Livertox Database. https://livertox.nlm.nih.gov/Ephedra.htm. Updated October 16, 2017. Accessed November 1, 2017.

Lai S, Yu C, Dennehy CE, Tsourounis C, Lee KP. Online marketing of Ephedra weight loss supplements: Labeling and marketing compliance with the U.S. Food and Drug Administration ban on Ephedra. J Altern Complement Med 2021;27(9):796-802. View abstract.

Park YJ, Cominguez DC, Kim HJ, et al. Therapeutic effects of Gambi-jung for the treatment of obesity. Biomed Pharmacother 2021;141:111838. View abstract.